Product Description
Tenvir-Em, marketed by Cipla Limited, is a remarkable antiretroviral and antiviral tablet renowned for its favorable reviews and glorious track record in HIV-1 infection treatment and prophylaxis (PrEP). Manufactured under pharmaceutical-grade standards, each blue, oblong film-coated tablet contains Emtricitabine 200 mg and Tenofovir Disoproxil Fumarate 300 mg, delivering consistent efficacy with unbeatable price deals. With a shelf life of 2-3 years in HDPE bottles and strict quality assurance, Tenvir-Em is trusted by healthcare professionals worldwide. Prescription required. One tablet daily or as prescribed.
Tenvir-Em: Comprehensive HIV Prevention and Treatment
Tenvir-Em is specifically used for treating and preventing HIV-1 infection, making it invaluable for both PrEP and ongoing antiviral therapy. Its general application extends to individuals at risk of or diagnosed with HIV, providing reliable viral suppression. The competitive advantages include its favorable safety profile, reliable dosing, and notable availability at an unbeatable price. Remarked for its clinical efficacy, Tenvir-Em remains a first-choice therapy, trusted by healthcare providers globally.
Tenvir-Em Sample Policy, Packaging, and Delivery
Our sample policy supports product valuation with easy access upon purchase order confirmation, ensuring clarity for both distributors and wholesalers. Tenvir-Em is securely packaged in HDPE bottles, each containing 30 film-coated tablets, guaranteeing product integrity. Delivery services span the main domestic market and international export, providing swift and reliable access. All shipments arrive with proper documentation to support purchase orders and build trust among our traders and partners.
FAQs of Tenvir-Em:
Q: How should Tenvir-Em be stored for maximum shelf life?
A: Tenvir-Em should be stored below 30C in a dry place, inside its HDPE bottle, to maintain its effectiveness throughout its 2-3 year shelf life.
Q: What is the specific usage of Tenvir-Em?
A: Tenvir-Em is used both for treating HIV-1 infection and as a pre-exposure prophylaxis (PrEP) to help prevent HIV transmission.
Q: When should I take Tenvir-Em tablets?
A: Tenvir-Em is taken orally, usually one tablet daily, or as prescribed by your healthcare provider, to ensure maximum benefit.
Q: Where is Tenvir-Em manufactured and marketed?
A: Tenvir-Em is manufactured in India and marketed by Cipla Limited, a renowned leader in pharmaceutical innovations.
Q: What competitive benefits does Tenvir-Em offer over other antiretrovirals?
A: Tenvir-Em provides a favorable safety profile, remarkable antiviral efficacy, and is available at an unbeatable price, making it a preferred option for both patients and healthcare providers.
Q: How is Tenvir-Em packaged for delivery?
A: Each Tenvir-Em order is securely packaged in HDPE bottles, with 30 film-coated, blue, oblong tablets per bottle, ensuring safe and convenient handling during shipment.